Parenteral Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Published on : Jan-2020 | List of Tables : 63 | List of Figures : 88 | No. of Pages : 170 | Report Code : FACT3189MR | Format :

Parenteral Drugs Market gains Traction, Driven by Automation in Drug Production and Inclination towards Single-use Equipment

Many parenteral drug manufacturers are adopting a single-use strategy for antibodies, proteins, cell therapy, vaccines, and gene therapy. FDA recommends the use of automation in pharmaceutical manufacturing. While continuous manufacturing offers both time and cost benefits; automated production reduces labour cost. However, for biologics and other advanced products, a cost-efficient and automated technology is yet to be developed. Furthermore, parenteral drug manufactures are currently focused on maintaining high quality of their products. Single-use technology maintains the quality of biologic parenteral drugs. Additionally, manufacturers are making efforts to incorporate Quality by Design (QbD) in their processes. On this premise, the parenteral drugs market is poised to reach a staggering valuation of US $ 802Bn by the end of the forecast period (2019-2029)

Increased Spending on Biologic Drugs to Shape Parenteral Drugs Market

There were nearly 500 parenteral drugs in the pipeline as of 2018. Increase in R&D spending in the pharmaceutical industry offers an opportunity for large molecule drugs to enter the pipeline. Oncology continues to remain the key research focus owing to the large patient pool that offers significant growth opportunities once the drug is launched in the market. The proportion of drugs in the pipeline requiring parenteral administration rose by ~2%, from 2018 to 2019. This is primarily due to the rise in the number of biologic drugs in the market. Most biologic drugs are available in injectable form, thus increasing the number of parenteral drugs in the pipeline, thereby driving the growth of the parenteral drugs market.

parenteral drugs market 01

To get strategic insights on the parenteral drugs market, request for a report sample here

Monoclonal Antibodies in the Forefront, Large Molecule Parenteral Drugs Gaining Traction

In terms of share analysis by product, monoclonal antibodies (mAb) led the global market, contributing a revenue share of 20% in 2018. Revenue shares from monoclonal antibodies product type segment are foreseen to increase primarily due to the expanding product pipeline and high number of product approvals by the FDA.  The segment of large molecules parenteral drugs will see an upward year on year growth trajectory as is seen in the figure below with growth steadying out after mid-term forecast. Large molecule drugs are biological injectable preparations which are administered to treat chronic disease like cancer, diabetes and blood diseases. Large molecules segment is a key focus area of the pharmaceutical industry at present. This is due to the highly biocompatible nature of large molecules. Approval for large molecules and biosimilars is a long and lengthy process that requires a significantly high investment for research.

parenteral drugs market 03

To get strategic and in-depth insights on the product share analysis of the parenteral drugs market, ask an analyst here

Big Pharmas Eyeing Untapped Markets for Stronger Foothold

Big pharmaceutical companies are acquiring smaller firms in emerging markets in Asia Pacific for sustainable growth. In terms of distribution, hospital pharmacies accounted for the maximum revenue share on the back of increased hospitalization and availability of skilled manpower. This was followed closely behind by retail pharmacies. Companies in the parenteral drugs market are focusing on geographical expansions and establishing their new facilities close to target markets. They are also consolidating their existing manufacturing capabilities to capture a larger market share.

Parenteral Drugs Market – Report Scope

Fact.MR recently published a market study on the global market for parenteral drugs. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities, and restraints, as well as detailed information about the parenteral drugs market structure. The market study presents exclusive information about how the parenteral drugs market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include year-on-year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the parenteral drugs market during the forecast period.

The study is relevant for stakeholders in the parenteral drugs market, including, manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the parenteral drugs market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the parenteral drugs market. Furthermore, small businesses and new entrants in the parenteral drugs market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Segments of Parenteral Drugs Market

Fact.MR’s study on the parenteral drugs market offers information divided into six important segments— product type, application, molecule type, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

Application

Molecule Type

Route of Administration

Distribution Channel

Region

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Others
  • Oncology
  • Infectious Diseases
  • Diabetes
  • Blood disorders
  • Hormonal Disorders
  • Musculoskeletal Disorders
  • CNS Diseases
  • Pain Management
  • Cardiovascular Diseases

 

  • Small Molecules
  • Large Molecules
  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in Fact.MR’s Parenteral Drugs Market Report

  • Which regions will continue to remain the most profitable regional markets for parenteral drugs market players?
  • Which factors will induce a change in demand for parenteral drug manufacturers during the assessment period?
  • How will changing trends impact the parenteral drugs market?
  • How can market players capture the low-hanging opportunities in the parenteral drugs market in developed regions?
  • Which companies are leading the parenteral drugs market?
  • What are the winning strategies of stakeholders in the parenteral drugs market to upscale their position in this landscape?

Parenteral Drugs Market: Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the parenteral drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the parenteral drugs market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the parenteral drugs market, and makes Fact.MR’s projection on the growth prospects of the parenteral drugs market more accurate and reliable.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Key Success Factors

    4.1. Key Disease Epidemiology

    4.2. Pipeline Analysis

    4.3. Key Regulations

    4.4. Supply Chain Analysis 

5. Global Parenteral Drug Market Demand (in Value or Size in US$ Bn) Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Bn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Bn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Generic Versions Intensify Total Sale

        6.1.2. Plant Upgrades Pushing Pricing of Parenteral Drugs

        6.1.3. Favorable Reimbursement Scenario Fuels the Market Growth

    6.2. Forecast Factors - Relevance & Impact

        1.1.1. Product Cost

        1.1.2. Frequency of Product Lunches 

        1.1.3. Per Patient Spending

        1.1.4. Product Awareness

        1.1.5. Products in Pipeline

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029, by Product Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2014 - 2018

    7.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2019 - 2029

        7.3.1. Monoclonal Antibodies

        7.3.2. Immunoglobulin

        7.3.3. Cytokines

        7.3.4. Insulin

        7.3.5. Peptide Hormones

        7.3.6. Blood Factors

        7.3.7. Peptide Antibiotics

        7.3.8. Vaccines

        7.3.9. Small Molecule Antibiotics

        7.3.10. Chemotherapy Agents

        7.3.11. Others 

    7.4. Market Attractiveness Analysis By Product Type 

8. Global Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029, by Molecule Type 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Bn) Analysis By Molecule Type, 2014 - 2018

    8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Molecule Type, 20s19 - 2029

        8.3.1. T Small Molecule

        8.3.2. Large Molecule

    8.4. Market Attractiveness Analysis By Molecule Type 

9. Global Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029, by Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Bn) Analysis By Route of Administration, 2018 - 2018

    9.3. Current and Future Market Size (US$ Bn) Analysis and By Route of Administration, 2019-2029

        9.3.1. Intravenous (IV)

        9.3.2. Intramuscular (IM)

        9.3.3. Subcutaneous (SC)

    9.4. Market Attractiveness Analysis By Route of Administration

10. Global Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029, by Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Bn) Analysis By Application, 2018 - 2018

    10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2019-2029

        10.3.1. Oncology

        10.3.2. Infectious Diseases

        10.3.3. Diabetes

        10.3.4. Blood Disorders

        10.3.5. Hormonal Disorders

        10.3.6. Musculoskeletal Disorders

        10.3.7. CNS Diseases

        10.3.8. Pain Management

        10.3.9. Cardiovascular Diseases

    10.4. Market Attractiveness Analysis By Application

11. Global Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029, by Distribution Channel

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2018 - 2018

    11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2019-2029

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Drug Stores

        11.3.4. Online Pharmacies 

    11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Bn) Analysis By Region, 2018 - 2018

    12.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2019-2029

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Middle East and Africa (MEA)

        12.3.5. East Asia

        12.3.6. South Asia

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis By Region

13. North America Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    13.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        13.3.1.  By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product Type

        13.3.3. By Molecule Type

        13.3.4. By Route of Administration

        13.3.5. By Application

        13.3.6. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

14. Latin America Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    14.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product Type

        14.3.3. By Molecule Type

        14.3.4. By Route of Administration

        14.3.5. By Application

        14.3.6. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

15. Europe Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    15.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        15.3.1.  By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product Type

        15.3.3. By Molecule Type

        15.3.4. By Route of Administration

        15.3.5. By Application

        15.3.6. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

16. South Asia Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    16.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        16.3.1.  By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product Type

        16.3.3. By Molecule Type

        16.3.4. By Route of Administration

        16.3.5. By Application

        16.3.6. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

17. East Asia Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    17.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        17.3.1.  By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product Type

        17.3.3. By Molecule Type

        17.3.4. By Route of Administration

        17.3.5. By Application

        17.3.6. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

18. Oceania Parenteral Drug Market 2014-2018 and Forecast, 2019-2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    18.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product Type

        18.3.3. By Molecule Type

        18.3.4. By Route of Administration

        18.3.5. By Application

        18.3.6. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

19. Middle East and Africa Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    19.1. Introduction

    19.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 - 2018

    19.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2019-2029

        19.3.1.  By Country

            19.3.1.1. GCC Countries

            19.3.1.2. South Africa

            19.3.1.3. Rest of Middle East and Africa

        19.3.2. By Product Type

        19.3.3. By Molecule Type

        19.3.4. By Route of Administration

        19.3.5. By Application

        19.3.6. By Distribution Channel

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

20. Emerging Countries Parenteral Drug Market Analysis 2014-2018 and Forecast, 2019-2029

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. China Parenteral Drug Market Analysis

        20.2.1. Market Value Proportion Analysis by Market Taxonomy

        20.2.2. Market Value (US$ Bn) Analysis and Forecast by Market Taxonomy

            20.2.2.1. By Product Type

            20.2.2.2. By Molecule Type

            20.2.2.3. By Route of Administration

            20.2.2.4. By Application

            20.2.2.5. By Distribution Channel

    20.3. India Parenteral Drug Market Analysis

        20.3.1. Market Value Proportion Analysis by Market Taxonomy

        20.3.2. Market Value (US$ Bn) Analysis and Forecast by Market Taxonomy

            20.3.2.1. By Product Type

            20.3.2.2. By Molecule Type

            20.3.2.3. By Route of Administration

            20.3.2.4. By Application

            20.3.2.5. By Distribution Channel

    20.4. Brazil Parenteral Drug Market Analysis

        20.4.1. Market Value Proportion Analysis by Market Taxonomy

        20.4.2. Market Value (US$ Bn) Analysis and Forecast by Market Taxonomy

            20.4.2.1. By Product Type

            20.4.2.2. By Molecule Type

            20.4.2.3. By Route of Administration

            20.4.2.4. By Application

            20.4.2.5. By Distribution Channel

21. Competition Analysis

    21.1. Competition Deep Dive 

        21.1.1. Pfizer Inc.

            21.1.1.1. Overview

            21.1.1.2. Product Portfolio

            21.1.1.3. Sales Footprint

            21.1.1.4. Key Financials 

        21.1.2. Novartis AG 

            21.1.2.1. Overview

            21.1.2.2. Product Portfolio

            21.1.2.3. Sales Footprint

            21.1.2.4. Key Financials 

        21.1.3. Teva Pharmaceutical Industries Ltd. 

            21.1.3.1. Overview

            21.1.3.2. Product Portfolio

            21.1.3.3. Sales Footprint

            21.1.3.4. Key Financials 

        21.1.4. Sanofi S.A. 

            21.1.4.1. Overview

            21.1.4.2. Product Portfolio

            21.1.4.3. Sales Footprint

            21.1.4.4. Key Financials 

        21.1.5. Sun Pharmaceutical Industries Ltd. 

            21.1.5.1. Overview

            21.1.5.2. Product Portfolio

            21.1.5.3. Sales Footprint

            21.1.5.4. Key Financials 

        21.1.6. AstraZeneca Plc 

            21.1.6.1. Overview

            21.1.6.2. Product Portfolio

            21.1.6.3. Sales Footprint

            21.1.6.4. Key Financials 

        21.1.7. Merck & Co., Inc. 

            21.1.7.1. Overview

            21.1.7.2. Product Portfolio

            21.1.7.3. Sales Footprint

            21.1.7.4. Key Financials 

        21.1.8. Mylan N.V

            21.1.8.1. Overview

            21.1.8.2. Product Portfolio

            21.1.8.3. Sales Footprint

            21.1.8.4. Key Financials 

        21.1.9. Cipla Inc. 

            21.1.9.1. Overview

            21.1.9.2. Product Portfolio

            21.1.9.3. Sales Footprint

            21.1.9.4. Key Financials 

        21.1.10. Dr. Reddy’s Laboratories Ltd. 

            21.1.10.1. Overview

            21.1.10.2. Product Portfolio

            21.1.10.3. Sales Footprint

            21.1.10.4. Key Financials 

        21.1.11. Samsung Biologics 

            21.1.11.1. Overview

            21.1.11.2. Product Portfolio

            21.1.11.3. Sales Footprint

            21.1.11.4. Key Financials 

22. Assumptions and Acronyms Used

23. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Parenteral Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029